NF-κB mediates the antiproliferative and proapoptotic effects of bergamot juice in HepG2 cells

Published on Feb 1, 2016in Life Sciences
5.04
· DOI :10.1016/j.lfs.2015.12.040
Nadia Ferlazzo25
Estimated H-index: 25
(UNIME: University of Messina),
Santa Cirmi20
Estimated H-index: 20
(UNIME: University of Messina)
+ 6 AuthorsMichele Navarra40
Estimated H-index: 40
(UNIME: University of Messina)
Source
Abstract
Abstract null null Aims null Among cancers, hepatocellular carcinoma is one of the commonest worldwide, and its incidence is increasing around the world. A lot of evidence underlines that natural substances usually consumed in the diet can have an important role in the prevention of cancer. In this study we investigated the molecular mechanisms underlying the antiproliferative activity of Citrus bergamia (bergamot) juice (BJ) in human hepatocellular carcinoma HepG2 cells. null null null Main methods null HepG2 cells were exposed to BJ and then cell proliferation, cell cycle progression, apoptosis and NF-κB nuclear translocation were evaluated. null null null Key findings null Here we present results demonstrating that BJ reduced the growth rate of human hepatocellular carcinoma HepG2 cells in a time- and concentration-dependent manner, by a mechanism involving the activation of apoptotic machinery via both intrinsic and extrinsic pathways. Moreover, BJ increased expression of P53 and P21 proteins that may be responsible for the HepG2 cell cycle arrest in G2 phase. In addition, BJ reduced NF-κB nuclear translocation. null null null Significance null Our data demonstrate the ability of BJ in reducing the growth of HepG2 cells, revealing its mechanism of action and suggesting a promising role as anticancer drugs.
References62
Cited By46
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.